Literature DB >> 4177929

Potassium, glucose, and insulin treatment for acute myocardial infarction.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4177929

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  High glucose protects embryonic cardiac cells against simulated ischemia.

Authors:  Vassiliki Malliopoulou; Christodoulos Xinaris; Iordanis Mourouzis; Alexandros D Cokkinos; Nikolaos Katsilambros; Constantinos Pantos; Elissavet Kardami; Dennis V Cokkinos
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

2.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 3.  Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.

Authors:  L M King; L H Opie
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

4.  A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Authors:  Mamas A Mamas; Ludwig Neyses; Farzin Fath-Ordoubadi
Journal:  Exp Clin Cardiol       Date:  2010

5.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

6.  Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine].

Authors:  H Korb; A Hoeft; D H Hunneman; R Schraeder; H G Wolpers; W Wober; G Hellige
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

7.  Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.

Authors:  Salim Yusuf; Shamir R Mehta; Rafael Díaz; Ernesto Paolasso; Prem Pais; Denis Xavier; Changchun Xie; Rashid J Ahmed; Khawar Khazmi; Jun Zhu; Lisheng Liu
Journal:  Am Heart J       Date:  2004-12       Impact factor: 4.749

8.  Glycemic Control during Coronary Artery Bypass Graft Surgery.

Authors:  Harold L Lazar
Journal:  ISRN Cardiol       Date:  2012-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.